ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,678Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 337

$894K Total Retail Price of All Prescriptions

Rank: 15 out of 337

760 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 760 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 760 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 13,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OMEPRAZOLE 700 568 1 4
HYDROCODONE-ACETAMINOPHEN 690 482 S3 2 13
SIMVASTATIN 630 529 3 1
LISINOPRIL 601 502 4 2
AMLODIPINE BESYLATE 545 484 5 3
FUROSEMIDE 527 424 6 8
LEVOTHYROXINE SODIUM 512 444 7 5
ATORVASTATIN CALCIUM 480 443 8 7
HYDROCHLOROTHIAZIDE 471 363 9 9
METOPROLOL TARTRATE 454 409 10 6
CITALOPRAM HBR 384 301 11 17
OXYCODONE HCL 340 182 S2 12 63
ATENOLOL 301 256 13 10
LOSARTAN POTASSIUM 275 231 14 15
GLIMEPIRIDE 238 190 15 55
METFORMIN HCL 234 150 16 12
SYNTHROID 201 177 17 41
METOPROLOL SUCCINATE 200 186 18 21
ZOLPIDEM TARTRATE 175 130 19 23
NEXIUM 172 101 20 56
OXYCODONE-ACETAMINOPHEN 162 90 S2 21 84
ALENDRONATE SODIUM 160 133 22 19
WARFARIN SODIUM 150 143 23 11
TRAZODONE HCL 145 109 24 16
GLYBURIDE 143 80 R 25 53
FLUTICASONE PROPIONATE 140 101 26 34
NABUMETONE 129 104 27 258
DIOVAN 124 101 28 26
AZITHROMYCIN 123 97 29 51
DIOVAN HCT 119 117 30 88
SERTRALINE HCL 118 84 31 18
FLUOXETINE HCL 117 52 32 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 79 32 31
PRAVASTATIN SODIUM 115 115 34 14
LANTUS 108 83 35 49
MELOXICAM 104 95 36 54
SPIRIVA 104 89 36 43
OXYCODONE HCL-ACETAMINOPHEN 102 26 S2 38 152
LIPITOR 101 87 39 33
CELEBREX 100 75 40 116
LOSARTAN-HYDROCHLOROTHIAZIDE 99 83 41 60
PROAIR HFA 98 49 42 38
PREDNISONE 98 93 42 40
PANTOPRAZOLE SODIUM 97 80 44 36
ALLOPURINOL 97 97 44 28
AMITRIPTYLINE HCL 96 52 R 46 75
CLOPIDOGREL 94 81 47 42
POLYETHYLENE GLYCOL 3350 91 62 48 47
ESCITALOPRAM OXALATE 91 86 48 66
TRAMADOL HCL 87 48 50 32
LEVOXYL 85 85 51 90
DONEPEZIL HCL 84 84 52 22
GABAPENTIN 83 73 53 20
OXYCONTIN 80 40 S2 54 87
TRIAMTERENE-HCTZ 76 68 55 39
CRESTOR 75 67 56 29
COLCRYS 73 73 57 128
JANUVIA 73 63 57 81
PREMARIN 68 44 R 59 263
ENALAPRIL MALEATE 68 55 59 37
TAMSULOSIN HCL 67 67 61 25
CYMBALTA 66 52 62 59
DIGOXIN 66 62 62 58
ADVAIR DISKUS 66 48 62 44
LOVASTATIN 65 52 65 24
AMLODIPINE BESYLATE-BENAZEPRIL 64 62 66 97
PAROXETINE HCL 64 64 66 46
CYCLOBENZAPRINE HCL 64 38 R 66 103
IBUPROFEN 62 36 69 64
CARISOPRODOL 62 0 R 69 180
MECLIZINE HCL 61 56 71 117
RANITIDINE HCL 61 38 71 30
BETAMETHASONE DIPROPIONATE 61 48 71 244
GLIPIZIDE ER 60 57 74 69
PLAVIX 60 51 74 74
TRICOR 60 60 74 134
LORAZEPAM 57 50 77 119
CIPROFLOXACIN HCL 57 47 77 71
RISPERIDONE 56 11 79 72
AMPHETAMINE SALT COMBO 56 15 S2 79 306
SINGULAIR 55 36 81 113
POTASSIUM CHLORIDE 53 44 82 62
ROPINIROLE HCL 53 39 82 141
GLYBURIDE-METFORMIN HCL 52 33 R 84 99
GLIPIZIDE 51 42 85 45
LEVOFLOXACIN 51 39 85 93
HYDRALAZINE HCL 51 46 85 122
AMLODIPINE-ATORVASTATIN 51 51 85 243
JANUMET 50 37 89 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.